nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—Nucleoside Reverse Transcriptase Inhibitors—Zidovudine—acquired immunodeficiency syndrome	0.156	0.184	CiPCiCtD
Abacavir—Nucleoside Reverse Transcriptase Inhibitors—Stavudine—acquired immunodeficiency syndrome	0.156	0.184	CiPCiCtD
Abacavir—Nucleoside Reverse Transcriptase Inhibitors—Didanosine—acquired immunodeficiency syndrome	0.156	0.184	CiPCiCtD
Abacavir—Nucleoside Reverse Transcriptase Inhibitors—Lamivudine—acquired immunodeficiency syndrome	0.118	0.139	CiPCiCtD
Abacavir—Nucleoside Analog—Zidovudine—acquired immunodeficiency syndrome	0.0702	0.0826	CiPCiCtD
Abacavir—Nucleoside Analog—Stavudine—acquired immunodeficiency syndrome	0.0702	0.0826	CiPCiCtD
Abacavir—Nucleoside Analog—Didanosine—acquired immunodeficiency syndrome	0.0702	0.0826	CiPCiCtD
Abacavir—Nucleoside Analog—Lamivudine—acquired immunodeficiency syndrome	0.0532	0.0626	CiPCiCtD
Abacavir—ADH6—digestive system—acquired immunodeficiency syndrome	0.00301	0.185	CbGeAlD
Abacavir—ADH6—lung—acquired immunodeficiency syndrome	0.00251	0.155	CbGeAlD
Abacavir—Cladribine—POLE3—acquired immunodeficiency syndrome	0.00242	1	CrCbGaD
Abacavir—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.00179	0.11	CbGeAlD
Abacavir—ADK—retina—acquired immunodeficiency syndrome	0.000993	0.0612	CbGeAlD
Abacavir—ADK—skin of body—acquired immunodeficiency syndrome	0.000872	0.0537	CbGeAlD
Abacavir—ADK—lymphoid tissue—acquired immunodeficiency syndrome	0.000706	0.0435	CbGeAlD
Abacavir—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.000688	0.0424	CbGeAlD
Abacavir—ADK—blood—acquired immunodeficiency syndrome	0.000664	0.0409	CbGeAlD
Abacavir—UGT1A1—blood—acquired immunodeficiency syndrome	0.000655	0.0404	CbGeAlD
Abacavir—ADK—bone marrow—acquired immunodeficiency syndrome	0.000643	0.0396	CbGeAlD
Abacavir—ADK—spinal cord—acquired immunodeficiency syndrome	0.00064	0.0394	CbGeAlD
Abacavir—ADK—vagina—acquired immunodeficiency syndrome	0.000616	0.0379	CbGeAlD
Abacavir—ADK—lung—acquired immunodeficiency syndrome	0.000582	0.0359	CbGeAlD
Abacavir—ADK—nervous system—acquired immunodeficiency syndrome	0.000539	0.0332	CbGeAlD
Abacavir—ADK—central nervous system—acquired immunodeficiency syndrome	0.000519	0.032	CbGeAlD
Abacavir—ADK—brain—acquired immunodeficiency syndrome	0.000412	0.0254	CbGeAlD
Abacavir—ADK—lymph node—acquired immunodeficiency syndrome	0.000398	0.0245	CbGeAlD
Abacavir—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	3.91e-05	0.000298	CcSEcCtD
Abacavir—Malaise—Ritonavir—acquired immunodeficiency syndrome	3.91e-05	0.000298	CcSEcCtD
Abacavir—Vertigo—Ritonavir—acquired immunodeficiency syndrome	3.89e-05	0.000297	CcSEcCtD
Abacavir—Pain—Zidovudine—acquired immunodeficiency syndrome	3.89e-05	0.000297	CcSEcCtD
Abacavir—Asthenia—Nevirapine—acquired immunodeficiency syndrome	3.89e-05	0.000296	CcSEcCtD
Abacavir—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	3.88e-05	0.000296	CcSEcCtD
Abacavir—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	3.88e-05	0.000296	CcSEcCtD
Abacavir—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	3.87e-05	0.000295	CcSEcCtD
Abacavir—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	3.87e-05	0.000295	CcSEcCtD
Abacavir—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	3.85e-05	0.000294	CcSEcCtD
Abacavir—Anaemia—Saquinavir—acquired immunodeficiency syndrome	3.85e-05	0.000294	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	3.85e-05	0.000294	CcSEcCtD
Abacavir—Pruritus—Nevirapine—acquired immunodeficiency syndrome	3.83e-05	0.000292	CcSEcCtD
Abacavir—Vomiting—Didanosine—acquired immunodeficiency syndrome	3.83e-05	0.000292	CcSEcCtD
Abacavir—Insomnia—Indinavir—acquired immunodeficiency syndrome	3.82e-05	0.000292	CcSEcCtD
Abacavir—Oedema—Delavirdine—acquired immunodeficiency syndrome	3.82e-05	0.000292	CcSEcCtD
Abacavir—Anorexia—Efavirenz—acquired immunodeficiency syndrome	3.81e-05	0.00029	CcSEcCtD
Abacavir—Rash—Didanosine—acquired immunodeficiency syndrome	3.8e-05	0.00029	CcSEcCtD
Abacavir—Infection—Delavirdine—acquired immunodeficiency syndrome	3.8e-05	0.00029	CcSEcCtD
Abacavir—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	3.8e-05	0.00029	CcSEcCtD
Abacavir—Dermatitis—Didanosine—acquired immunodeficiency syndrome	3.8e-05	0.000289	CcSEcCtD
Abacavir—Cough—Ritonavir—acquired immunodeficiency syndrome	3.78e-05	0.000288	CcSEcCtD
Abacavir—Headache—Didanosine—acquired immunodeficiency syndrome	3.77e-05	0.000288	CcSEcCtD
Abacavir—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	3.77e-05	0.000288	CcSEcCtD
Abacavir—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	3.76e-05	0.000287	CcSEcCtD
Abacavir—Malaise—Saquinavir—acquired immunodeficiency syndrome	3.76e-05	0.000287	CcSEcCtD
Abacavir—Asthenia—Stavudine—acquired immunodeficiency syndrome	3.75e-05	0.000286	CcSEcCtD
Abacavir—Convulsion—Ritonavir—acquired immunodeficiency syndrome	3.75e-05	0.000286	CcSEcCtD
Abacavir—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	3.75e-05	0.000286	CcSEcCtD
Abacavir—Vertigo—Saquinavir—acquired immunodeficiency syndrome	3.74e-05	0.000286	CcSEcCtD
Abacavir—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	3.74e-05	0.000285	CcSEcCtD
Abacavir—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	3.73e-05	0.000285	CcSEcCtD
Abacavir—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	3.72e-05	0.000284	CcSEcCtD
Abacavir—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	3.71e-05	0.000283	CcSEcCtD
Abacavir—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	3.71e-05	0.000283	CcSEcCtD
Abacavir—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	3.71e-05	0.000283	CcSEcCtD
Abacavir—Pruritus—Stavudine—acquired immunodeficiency syndrome	3.7e-05	0.000282	CcSEcCtD
Abacavir—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	3.69e-05	0.000281	CcSEcCtD
Abacavir—Myalgia—Ritonavir—acquired immunodeficiency syndrome	3.69e-05	0.000281	CcSEcCtD
Abacavir—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	3.69e-05	0.000281	CcSEcCtD
Abacavir—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	3.68e-05	0.00028	CcSEcCtD
Abacavir—Anaemia—Lamivudine—acquired immunodeficiency syndrome	3.68e-05	0.00028	CcSEcCtD
Abacavir—Anxiety—Ritonavir—acquired immunodeficiency syndrome	3.67e-05	0.00028	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	3.66e-05	0.000279	CcSEcCtD
Abacavir—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	3.65e-05	0.000278	CcSEcCtD
Abacavir—Fatigue—Indinavir—acquired immunodeficiency syndrome	3.65e-05	0.000278	CcSEcCtD
Abacavir—Anorexia—Delavirdine—acquired immunodeficiency syndrome	3.64e-05	0.000278	CcSEcCtD
Abacavir—Discomfort—Ritonavir—acquired immunodeficiency syndrome	3.64e-05	0.000278	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	3.64e-05	0.000278	CcSEcCtD
Abacavir—Cough—Saquinavir—acquired immunodeficiency syndrome	3.64e-05	0.000277	CcSEcCtD
Abacavir—Pain—Indinavir—acquired immunodeficiency syndrome	3.62e-05	0.000276	CcSEcCtD
Abacavir—Insomnia—Efavirenz—acquired immunodeficiency syndrome	3.61e-05	0.000276	CcSEcCtD
Abacavir—Urticaria—Zidovudine—acquired immunodeficiency syndrome	3.61e-05	0.000275	CcSEcCtD
Abacavir—Convulsion—Saquinavir—acquired immunodeficiency syndrome	3.61e-05	0.000275	CcSEcCtD
Abacavir—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	3.59e-05	0.000274	CcSEcCtD
Abacavir—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.59e-05	0.000274	CcSEcCtD
Abacavir—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.59e-05	0.000274	CcSEcCtD
Abacavir—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	3.59e-05	0.000274	CcSEcCtD
Abacavir—Malaise—Lamivudine—acquired immunodeficiency syndrome	3.59e-05	0.000274	CcSEcCtD
Abacavir—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.58e-05	0.000273	CcSEcCtD
Abacavir—Nausea—Didanosine—acquired immunodeficiency syndrome	3.58e-05	0.000273	CcSEcCtD
Abacavir—Vertigo—Lamivudine—acquired immunodeficiency syndrome	3.57e-05	0.000273	CcSEcCtD
Abacavir—Hypotension—Delavirdine—acquired immunodeficiency syndrome	3.57e-05	0.000272	CcSEcCtD
Abacavir—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	3.56e-05	0.000272	CcSEcCtD
Abacavir—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	3.56e-05	0.000272	CcSEcCtD
Abacavir—Myalgia—Saquinavir—acquired immunodeficiency syndrome	3.55e-05	0.000271	CcSEcCtD
Abacavir—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	3.55e-05	0.000271	CcSEcCtD
Abacavir—Anxiety—Saquinavir—acquired immunodeficiency syndrome	3.54e-05	0.00027	CcSEcCtD
Abacavir—Oedema—Ritonavir—acquired immunodeficiency syndrome	3.53e-05	0.00027	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	3.52e-05	0.000269	CcSEcCtD
Abacavir—Discomfort—Saquinavir—acquired immunodeficiency syndrome	3.51e-05	0.000267	CcSEcCtD
Abacavir—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	3.48e-05	0.000266	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	3.48e-05	0.000266	CcSEcCtD
Abacavir—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.47e-05	0.000265	CcSEcCtD
Abacavir—Cough—Lamivudine—acquired immunodeficiency syndrome	3.47e-05	0.000265	CcSEcCtD
Abacavir—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	3.47e-05	0.000265	CcSEcCtD
Abacavir—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	3.47e-05	0.000264	CcSEcCtD
Abacavir—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	3.46e-05	0.000264	CcSEcCtD
Abacavir—Dizziness—Stavudine—acquired immunodeficiency syndrome	3.46e-05	0.000264	CcSEcCtD
Abacavir—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	3.46e-05	0.000264	CcSEcCtD
Abacavir—Insomnia—Delavirdine—acquired immunodeficiency syndrome	3.46e-05	0.000264	CcSEcCtD
Abacavir—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	3.45e-05	0.000263	CcSEcCtD
Abacavir—Convulsion—Lamivudine—acquired immunodeficiency syndrome	3.45e-05	0.000263	CcSEcCtD
Abacavir—Vomiting—Nevirapine—acquired immunodeficiency syndrome	3.44e-05	0.000263	CcSEcCtD
Abacavir—Fatigue—Efavirenz—acquired immunodeficiency syndrome	3.44e-05	0.000263	CcSEcCtD
Abacavir—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	3.43e-05	0.000262	CcSEcCtD
Abacavir—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	3.43e-05	0.000262	CcSEcCtD
Abacavir—Pain—Efavirenz—acquired immunodeficiency syndrome	3.42e-05	0.000261	CcSEcCtD
Abacavir—Rash—Nevirapine—acquired immunodeficiency syndrome	3.42e-05	0.000261	CcSEcCtD
Abacavir—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.41e-05	0.00026	CcSEcCtD
Abacavir—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	3.41e-05	0.00026	CcSEcCtD
Abacavir—Oedema—Saquinavir—acquired immunodeficiency syndrome	3.4e-05	0.000259	CcSEcCtD
Abacavir—Headache—Nevirapine—acquired immunodeficiency syndrome	3.39e-05	0.000259	CcSEcCtD
Abacavir—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	3.39e-05	0.000258	CcSEcCtD
Abacavir—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.39e-05	0.000258	CcSEcCtD
Abacavir—Infection—Saquinavir—acquired immunodeficiency syndrome	3.38e-05	0.000258	CcSEcCtD
Abacavir—Anxiety—Lamivudine—acquired immunodeficiency syndrome	3.37e-05	0.000257	CcSEcCtD
Abacavir—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3.37e-05	0.000257	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	3.36e-05	0.000256	CcSEcCtD
Abacavir—Urticaria—Indinavir—acquired immunodeficiency syndrome	3.36e-05	0.000256	CcSEcCtD
Abacavir—Discomfort—Lamivudine—acquired immunodeficiency syndrome	3.34e-05	0.000255	CcSEcCtD
Abacavir—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	3.34e-05	0.000255	CcSEcCtD
Abacavir—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.34e-05	0.000255	CcSEcCtD
Abacavir—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	3.34e-05	0.000254	CcSEcCtD
Abacavir—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.34e-05	0.000254	CcSEcCtD
Abacavir—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	3.33e-05	0.000254	CcSEcCtD
Abacavir—Vomiting—Stavudine—acquired immunodeficiency syndrome	3.33e-05	0.000254	CcSEcCtD
Abacavir—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3.32e-05	0.000253	CcSEcCtD
Abacavir—Rash—Nelfinavir—acquired immunodeficiency syndrome	3.31e-05	0.000252	CcSEcCtD
Abacavir—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	3.3e-05	0.000252	CcSEcCtD
Abacavir—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	3.3e-05	0.000252	CcSEcCtD
Abacavir—Hypotension—Ritonavir—acquired immunodeficiency syndrome	3.3e-05	0.000252	CcSEcCtD
Abacavir—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	3.3e-05	0.000252	CcSEcCtD
Abacavir—Rash—Stavudine—acquired immunodeficiency syndrome	3.3e-05	0.000252	CcSEcCtD
Abacavir—Fatigue—Delavirdine—acquired immunodeficiency syndrome	3.3e-05	0.000251	CcSEcCtD
Abacavir—Dermatitis—Stavudine—acquired immunodeficiency syndrome	3.29e-05	0.000251	CcSEcCtD
Abacavir—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	3.29e-05	0.000251	CcSEcCtD
Abacavir—Headache—Nelfinavir—acquired immunodeficiency syndrome	3.29e-05	0.000251	CcSEcCtD
Abacavir—Headache—Stavudine—acquired immunodeficiency syndrome	3.28e-05	0.00025	CcSEcCtD
Abacavir—Pain—Delavirdine—acquired immunodeficiency syndrome	3.27e-05	0.000249	CcSEcCtD
Abacavir—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	3.27e-05	0.000249	CcSEcCtD
Abacavir—Asthenia—Zidovudine—acquired immunodeficiency syndrome	3.26e-05	0.000249	CcSEcCtD
Abacavir—Oedema—Lamivudine—acquired immunodeficiency syndrome	3.25e-05	0.000248	CcSEcCtD
Abacavir—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	3.25e-05	0.000248	CcSEcCtD
Abacavir—Anorexia—Saquinavir—acquired immunodeficiency syndrome	3.24e-05	0.000247	CcSEcCtD
Abacavir—Infection—Lamivudine—acquired immunodeficiency syndrome	3.22e-05	0.000246	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	3.22e-05	0.000246	CcSEcCtD
Abacavir—Nausea—Nevirapine—acquired immunodeficiency syndrome	3.22e-05	0.000245	CcSEcCtD
Abacavir—Pruritus—Zidovudine—acquired immunodeficiency syndrome	3.22e-05	0.000245	CcSEcCtD
Abacavir—Insomnia—Ritonavir—acquired immunodeficiency syndrome	3.2e-05	0.000244	CcSEcCtD
Abacavir—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	3.18e-05	0.000243	CcSEcCtD
Abacavir—Hypotension—Saquinavir—acquired immunodeficiency syndrome	3.18e-05	0.000242	CcSEcCtD
Abacavir—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	3.18e-05	0.000242	CcSEcCtD
Abacavir—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	3.17e-05	0.000242	CcSEcCtD
Abacavir—Urticaria—Efavirenz—acquired immunodeficiency syndrome	3.17e-05	0.000242	CcSEcCtD
Abacavir—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	3.16e-05	0.000241	CcSEcCtD
Abacavir—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	3.16e-05	0.000241	CcSEcCtD
Abacavir—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	3.15e-05	0.00024	CcSEcCtD
Abacavir—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	3.15e-05	0.00024	CcSEcCtD
Abacavir—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	3.15e-05	0.00024	CcSEcCtD
Abacavir—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	3.13e-05	0.000238	CcSEcCtD
Abacavir—Nausea—Nelfinavir—acquired immunodeficiency syndrome	3.12e-05	0.000238	CcSEcCtD
Abacavir—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	3.11e-05	0.000238	CcSEcCtD
Abacavir—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	3.11e-05	0.000237	CcSEcCtD
Abacavir—Nausea—Stavudine—acquired immunodeficiency syndrome	3.11e-05	0.000237	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	3.1e-05	0.000236	CcSEcCtD
Abacavir—Anorexia—Lamivudine—acquired immunodeficiency syndrome	3.09e-05	0.000236	CcSEcCtD
Abacavir—Insomnia—Saquinavir—acquired immunodeficiency syndrome	3.08e-05	0.000235	CcSEcCtD
Abacavir—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	3.07e-05	0.000234	CcSEcCtD
Abacavir—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	3.05e-05	0.000233	CcSEcCtD
Abacavir—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	3.05e-05	0.000233	CcSEcCtD
Abacavir—Fatigue—Ritonavir—acquired immunodeficiency syndrome	3.05e-05	0.000232	CcSEcCtD
Abacavir—Urticaria—Delavirdine—acquired immunodeficiency syndrome	3.04e-05	0.000232	CcSEcCtD
Abacavir—Asthenia—Indinavir—acquired immunodeficiency syndrome	3.03e-05	0.000231	CcSEcCtD
Abacavir—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	3.03e-05	0.000231	CcSEcCtD
Abacavir—Hypotension—Lamivudine—acquired immunodeficiency syndrome	3.03e-05	0.000231	CcSEcCtD
Abacavir—Pain—Ritonavir—acquired immunodeficiency syndrome	3.02e-05	0.000231	CcSEcCtD
Abacavir—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	3.02e-05	0.00023	CcSEcCtD
Abacavir—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	3.02e-05	0.00023	CcSEcCtD
Abacavir—Dizziness—Zidovudine—acquired immunodeficiency syndrome	3.01e-05	0.000229	CcSEcCtD
Abacavir—Pruritus—Indinavir—acquired immunodeficiency syndrome	2.99e-05	0.000228	CcSEcCtD
Abacavir—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	2.96e-05	0.000226	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	2.96e-05	0.000226	CcSEcCtD
Abacavir—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	2.94e-05	0.000224	CcSEcCtD
Abacavir—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	2.94e-05	0.000224	CcSEcCtD
Abacavir—Insomnia—Lamivudine—acquired immunodeficiency syndrome	2.94e-05	0.000224	CcSEcCtD
Abacavir—Fatigue—Saquinavir—acquired immunodeficiency syndrome	2.93e-05	0.000224	CcSEcCtD
Abacavir—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	2.91e-05	0.000222	CcSEcCtD
Abacavir—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	2.91e-05	0.000222	CcSEcCtD
Abacavir—Pain—Saquinavir—acquired immunodeficiency syndrome	2.91e-05	0.000222	CcSEcCtD
Abacavir—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	2.89e-05	0.000221	CcSEcCtD
Abacavir—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	2.89e-05	0.000221	CcSEcCtD
Abacavir—Vomiting—Zidovudine—acquired immunodeficiency syndrome	2.89e-05	0.00022	CcSEcCtD
Abacavir—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	2.89e-05	0.00022	CcSEcCtD
Abacavir—Rash—Zidovudine—acquired immunodeficiency syndrome	2.87e-05	0.000219	CcSEcCtD
Abacavir—Asthenia—Efavirenz—acquired immunodeficiency syndrome	2.87e-05	0.000219	CcSEcCtD
Abacavir—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	2.86e-05	0.000218	CcSEcCtD
Abacavir—Headache—Zidovudine—acquired immunodeficiency syndrome	2.85e-05	0.000217	CcSEcCtD
Abacavir—Pruritus—Efavirenz—acquired immunodeficiency syndrome	2.83e-05	0.000216	CcSEcCtD
Abacavir—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	2.82e-05	0.000215	CcSEcCtD
Abacavir—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	2.82e-05	0.000215	CcSEcCtD
Abacavir—Urticaria—Ritonavir—acquired immunodeficiency syndrome	2.81e-05	0.000214	CcSEcCtD
Abacavir—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	2.8e-05	0.000214	CcSEcCtD
Abacavir—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	2.8e-05	0.000214	CcSEcCtD
Abacavir—Fatigue—Lamivudine—acquired immunodeficiency syndrome	2.8e-05	0.000213	CcSEcCtD
Abacavir—Dizziness—Indinavir—acquired immunodeficiency syndrome	2.8e-05	0.000213	CcSEcCtD
Abacavir—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	2.79e-05	0.000213	CcSEcCtD
Abacavir—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	2.79e-05	0.000213	CcSEcCtD
Abacavir—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	2.78e-05	0.000212	CcSEcCtD
Abacavir—Pain—Lamivudine—acquired immunodeficiency syndrome	2.78e-05	0.000212	CcSEcCtD
Abacavir—Asthenia—Delavirdine—acquired immunodeficiency syndrome	2.74e-05	0.000209	CcSEcCtD
Abacavir—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.73e-05	0.000208	CcSEcCtD
Abacavir—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.7e-05	0.000206	CcSEcCtD
Abacavir—Urticaria—Saquinavir—acquired immunodeficiency syndrome	2.7e-05	0.000206	CcSEcCtD
Abacavir—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.7e-05	0.000206	CcSEcCtD
Abacavir—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	2.69e-05	0.000205	CcSEcCtD
Abacavir—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.69e-05	0.000205	CcSEcCtD
Abacavir—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.69e-05	0.000205	CcSEcCtD
Abacavir—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	2.67e-05	0.000204	CcSEcCtD
Abacavir—Rash—Indinavir—acquired immunodeficiency syndrome	2.67e-05	0.000203	CcSEcCtD
Abacavir—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.66e-05	0.000203	CcSEcCtD
Abacavir—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	2.65e-05	0.000202	CcSEcCtD
Abacavir—Headache—Indinavir—acquired immunodeficiency syndrome	2.65e-05	0.000202	CcSEcCtD
Abacavir—Dizziness—Efavirenz—acquired immunodeficiency syndrome	2.64e-05	0.000201	CcSEcCtD
Abacavir—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.62e-05	0.000199	CcSEcCtD
Abacavir—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2.6e-05	0.000199	CcSEcCtD
Abacavir—Urticaria—Lamivudine—acquired immunodeficiency syndrome	2.58e-05	0.000197	CcSEcCtD
Abacavir—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.57e-05	0.000196	CcSEcCtD
Abacavir—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	2.57e-05	0.000196	CcSEcCtD
Abacavir—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.54e-05	0.000194	CcSEcCtD
Abacavir—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.54e-05	0.000193	CcSEcCtD
Abacavir—Dizziness—Delavirdine—acquired immunodeficiency syndrome	2.53e-05	0.000193	CcSEcCtD
Abacavir—Rash—Efavirenz—acquired immunodeficiency syndrome	2.52e-05	0.000192	CcSEcCtD
Abacavir—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.52e-05	0.000192	CcSEcCtD
Abacavir—Nausea—Indinavir—acquired immunodeficiency syndrome	2.51e-05	0.000192	CcSEcCtD
Abacavir—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.51e-05	0.000191	CcSEcCtD
Abacavir—Headache—Efavirenz—acquired immunodeficiency syndrome	2.5e-05	0.000191	CcSEcCtD
Abacavir—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.5e-05	0.000191	CcSEcCtD
Abacavir—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.44e-05	0.000186	CcSEcCtD
Abacavir—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.43e-05	0.000185	CcSEcCtD
Abacavir—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.42e-05	0.000184	CcSEcCtD
Abacavir—Rash—Delavirdine—acquired immunodeficiency syndrome	2.41e-05	0.000184	CcSEcCtD
Abacavir—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.41e-05	0.000184	CcSEcCtD
Abacavir—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.41e-05	0.000184	CcSEcCtD
Abacavir—Headache—Delavirdine—acquired immunodeficiency syndrome	2.39e-05	0.000183	CcSEcCtD
Abacavir—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.39e-05	0.000182	CcSEcCtD
Abacavir—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.37e-05	0.000181	CcSEcCtD
Abacavir—Dizziness—Ritonavir—acquired immunodeficiency syndrome	2.34e-05	0.000178	CcSEcCtD
Abacavir—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.33e-05	0.000178	CcSEcCtD
Abacavir—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.33e-05	0.000178	CcSEcCtD
Abacavir—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.3e-05	0.000175	CcSEcCtD
Abacavir—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.27e-05	0.000173	CcSEcCtD
Abacavir—Dizziness—Saquinavir—acquired immunodeficiency syndrome	2.25e-05	0.000172	CcSEcCtD
Abacavir—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.25e-05	0.000171	CcSEcCtD
Abacavir—Rash—Ritonavir—acquired immunodeficiency syndrome	2.23e-05	0.00017	CcSEcCtD
Abacavir—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.23e-05	0.00017	CcSEcCtD
Abacavir—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.22e-05	0.000169	CcSEcCtD
Abacavir—Headache—Ritonavir—acquired immunodeficiency syndrome	2.21e-05	0.000169	CcSEcCtD
Abacavir—Vomiting—Saquinavir—acquired immunodeficiency syndrome	2.16e-05	0.000165	CcSEcCtD
Abacavir—Dizziness—Lamivudine—acquired immunodeficiency syndrome	2.15e-05	0.000164	CcSEcCtD
Abacavir—Rash—Saquinavir—acquired immunodeficiency syndrome	2.14e-05	0.000164	CcSEcCtD
Abacavir—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.14e-05	0.000163	CcSEcCtD
Abacavir—Headache—Saquinavir—acquired immunodeficiency syndrome	2.13e-05	0.000163	CcSEcCtD
Abacavir—Nausea—Ritonavir—acquired immunodeficiency syndrome	2.1e-05	0.00016	CcSEcCtD
Abacavir—Vomiting—Lamivudine—acquired immunodeficiency syndrome	2.06e-05	0.000157	CcSEcCtD
Abacavir—Rash—Lamivudine—acquired immunodeficiency syndrome	2.05e-05	0.000156	CcSEcCtD
Abacavir—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	2.04e-05	0.000156	CcSEcCtD
Abacavir—Headache—Lamivudine—acquired immunodeficiency syndrome	2.03e-05	0.000155	CcSEcCtD
Abacavir—Nausea—Saquinavir—acquired immunodeficiency syndrome	2.02e-05	0.000154	CcSEcCtD
Abacavir—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.93e-05	0.000147	CcSEcCtD
